SUCLG2 and glioblastoma: These findings suggest that SUCLG2 plays a central role in lactate-metabolism regulation and epigenetic regulation in GBM, offering new theoretical directions for targeted therapy and providing a solid theoretical foundation for multidimensional treatment strategies based on the metabolic–epigenetic axis.